Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1974 2
1984 1
1985 1
1997 1
1999 1
2004 2
2005 7
2006 3
2007 13
2008 18
2009 10
2010 9
2011 2
2012 4
2014 1
2015 1
2016 1
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 20688889

73 results
Results by year
Filters applied: . Clear all
Page 1
Natalizumab (Tysabri).
Selewski DT, Shah GV, Segal BM, Rajdev PA, Mukherji SK. Selewski DT, et al. AJNR Am J Neuroradiol. 2010 Oct;31(9):1588-90. doi: 10.3174/ajnr.A2226. Epub 2010 Aug 5. AJNR Am J Neuroradiol. 2010. PMID: 20688889 Free article. Review.
Natalizumab treatment reduces endothelial activity in MS patients.
Millonig A, Hegen H, Di Pauli F, Ehling R, Gneiss C, Hoelzl M, Künz B, Lutterotti A, Rudzki D, Berger T, Reindl M, Deisenhammer F. Millonig A, et al. J Neuroimmunol. 2010 Oct 8;227(1-2):190-4. doi: 10.1016/j.jneuroim.2010.07.012. Epub 2010 Aug 23. J Neuroimmunol. 2010. PMID: 20739072
Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale.
Rice GP, Hartung HP, Calabresi PA. Rice GP, et al. Neurology. 2005 Apr 26;64(8):1336-42. doi: 10.1212/01.WNL.0000158329.30470.D0. Neurology. 2005. PMID: 15851719 Review.
Natalizumab: targeting alpha4-integrins in multiple sclerosis.
Engelhardt B, Kappos L. Engelhardt B, et al. Neurodegener Dis. 2008;5(1):16-22. doi: 10.1159/000109933. Neurodegener Dis. 2008. PMID: 18075270 Review.
Natalizumab (Tysabri) for relapsing multiple sclerosis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2005 Feb 14;47(1202):13-5. Med Lett Drugs Ther. 2005. PMID: 15711498
Natalizumab (Tysabri) treatment for relapsing multiple sclerosis.
Johnson KP. Johnson KP. Neurologist. 2007 Jul;13(4):182-7. doi: 10.1097/01.nrl.0000263760.53418.5b. Neurologist. 2007. PMID: 17622909 Review.
[Natalizumab (Tysabri)].
Ravnborg M. Ravnborg M. Ugeskr Laeger. 2007 Sep 17;169(38):3184-7. Ugeskr Laeger. 2007. PMID: 17910826 Danish.
Natalizumab for multiple sclerosis?
[No authors listed] [No authors listed] Drug Ther Bull. 2008 Sep;46(9):69-72. doi: 10.1136/dtb.2008.09.0021. Drug Ther Bull. 2008. PMID: 18784381 Review.
Monoclonal antibodies in MS: mechanisms of action.
Bielekova B, Becker BL. Bielekova B, et al. Neurology. 2010 Jan 5;74 Suppl 1:S31-40. doi: 10.1212/WNL.0b013e3181c97ed3. Neurology. 2010. PMID: 20038761 Review.
73 results
Jump to page
Feedback